KREBS BIOCHEMICALS & INDUSTRIES
Back to Balance Sheet
|
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹104 Cr | ₹62 Cr | ₹49 Cr | ₹78 Cr | ₹48 Cr |
What is the latest Total Current Liabilities ratio of KREBS BIOCHEMICALS & INDUSTRIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹104 Cr |
| Mar2024 | ₹62 Cr |
| Mar2023 | ₹49 Cr |
| Mar2022 | ₹78 Cr |
| Mar2021 | ₹48 Cr |
How is Total Current Liabilities of KREBS BIOCHEMICALS & INDUSTRIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹104 Cr | 67.43 | |
| Mar2024 | ₹62 Cr | 25.92 | |
| Mar2023 | ₹49 Cr | -37.10 | |
| Mar2022 | ₹78 Cr | 61.99 | |
| Mar2021 | ₹48 Cr | - | |
Compare Total Current Liabilities of peers of KREBS BIOCHEMICALS & INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KREBS BIOCHEMICALS & INDUSTRIES | ₹149.3 Cr | 1.9% | 0.2% | -20.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,884.0 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,442.0 Cr | 1.8% | 1.3% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,770.0 Cr | 1.3% | 2.7% | 10% | Stock Analytics | |
| CIPLA | ₹120,871.0 Cr | -0.2% | -0.7% | 1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,693.0 Cr | -1% | 2.5% | -4.4% | Stock Analytics | |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KREBS BIOCHEMICALS & INDUSTRIES | 1.9% |
0.2% |
-20.9% |
| SENSEX | 1% |
0.6% |
7.8% |
You may also like the below Video Courses